NET Recovery Corp

NET Recovery Corp. develops and operates the NET Device™, an FDA-cleared transcutaneous alternating current stimulator (tACS) system for the management of opioid and kratom withdrawal symptoms. The device uses mild electrical stimulation delivered through two adhesive electrodes placed behind each ear to target the brain's reward pathway, providing rapid symptom relief typically within 20–45 minutes of treatment initiation. The company operates clinical treatment centers where patients receive device application, professional monitoring, and comprehensive support through once or twice-daily check-ins over a typical 3–4 day treatment course. NET Recovery is staffed by Advanced Practice Registered Nurses (APRNs) with specialized training in the NET Device protocol and does not dispense controlled substances. Currently available in Miami, Florida, the company offers private-pay neurostimulation services supported by peer-reviewed randomized controlled trial data demonstrating effective withdrawal symptom management and reduced post-discharge substance use. The device is indicated for use in conjunction with standard symptomatic medications and other therapies under trained clinical personnel supervision.